Skip to content

Heat Waves and the Elderly With COPD

Heat Waves and the Elderly With COPD: Reducing Thermal and Cardiovascular Consequences

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06295523
Enrollment
1
Registered
2024-03-06
Start date
2024-01-01
Completion date
2025-10-01
Last updated
2025-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Aging, Hyperthermia

Keywords

COPD, heat wave, thermoregulation

Brief summary

The purpose of this study is to investigate thermoregulatory responses in older individuals with COPD.

Detailed description

Heat waves are the leading cause of death among natural disasters in the United States. Elderly individuals are disproportionately more likely to become ill or die during heat waves. While the elderly have a reduced ability to regulate their body temperature,8-10 hospitalizations and deaths in this population during heat waves are primarily due to cardiovascular and/or respiratory complications, not solely hyperthermia. While previous research has primarily focused on the thermal and cardiovascular consequences of healthy aging, very little research has focused on the physiological responses to heat exposure in older individuals with chronic disease, such as chronic obstructive pulmonary disease (COPD). Notably, epidemiological data suggests that pulmonary complications are a leading cause of heat wave-related hospitalizations in older adults with a diagnosis of COPD, yet nothing is known regarding the physiological mechanisms by which those with COPD are most susceptible to heat waves. To fill this important gap, the investigators will identify the physiological responses that occur in this population, relative to healthy age-matched individuals, during two unique heat wave simulations.

Interventions

Participants will receive water spraying on their body throughout the climate chamber exposure.

OTHERControl

Participants will NOT receive water spraying on their body throughout the climate exposure.

Sponsors

American Heart Association
CollaboratorOTHER
University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 65 years old or older * Diagnosis of COPD

Exclusion criteria

* Known heart disease * Other chronic medical conditions requiring regular medical therapy including cancer, diabetes, uncontrolled hypertension, and uncontrolled hypercholesterolemia etc * Abnormality detected on routine screening suggestive of provokable ischemia or previously undetected cardiac disease or resting left bundle branch block on screening electrocardiogram * Current smokers * Participant with a body mass index ≥31 kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Core body temperaturePrior to and throughout each simulated heat wave exposure, an average of 480 minutesCore body temperature will be measure from gastrointestinal temperature via an ingestible telemetric pill
Forced expiratory volume (FEV1)Prior to, during, and after each simulated heat wave exposure, approximately 10 min eachFEV1 will be assessed via spirometry
Forced vital capacity (FVC)Prior to, during, and after each simulated heat wave exposure, approximately 10 min eachFVC will be assessed via spirometry
FEV1/FVC ratioPrior to, during, and after each simulated heat wave exposure, approximately 10 min eachThe ratio of forced expiratory volume and forced vital capacity will be assessed via spirometry

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026